tazobactam has been researched along with baclofen in 1 studies
Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (baclofen) | Trials (baclofen) | Recent Studies (post-2010) (baclofen) |
---|---|---|---|---|---|
1,327 | 153 | 694 | 6,017 | 372 | 1,535 |
Protein | Taxonomy | tazobactam (IC50) | baclofen (IC50) |
---|---|---|---|
Gamma-aminobutyric acid type B receptor subunit 2 | Homo sapiens (human) | 0.05 | |
Gamma-aminobutyric acid type B receptor subunit 2 | Rattus norvegicus (Norway rat) | 0.2762 | |
Gamma-aminobutyric acid type B receptor subunit 1 | Homo sapiens (human) | 0.05 | |
Gamma-aminobutyric acid type B receptor subunit 1 | Rattus norvegicus (Norway rat) | 0.2762 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greene, S; Kailainathan, R; Koutsogiannis, Z; Wong, A | 1 |
1 other study(ies) available for tazobactam and baclofen
Article | Year |
---|---|
Recognition of gamma-hydroxybutyric acid withdrawal: Rapid progression and prolonged symptomatology.
Topics: Adult; Anti-Bacterial Agents; Australia; Baclofen; Benzodiazepines; Diazepam; Humans; Hydroxybutyrates; Male; Penicillanic Acid; Phenobarbital; Piperacillin; Pneumonia; Psychomotor Agitation; Substance Withdrawal Syndrome; Sweating; Tazobactam; Tremor | 2017 |